DRRD reported in-line numbers with revenues of Rs 3850 crs (vs estimate of Rs3867crs), EBITDA Rs816crs (vs estimate of Rs 770 crs) and PAT Rs478crs (estimate Rs401crs). Healthy operating performance was led by (a) Steady revenue growth in the domestic formulation business (up 10% YoY)